Nathan Demars
Impact in
-
- Glioma Diagnosis and Treatment
- Virus-based gene therapy research
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
Papers in
- Oncology 12
- CAR-T cell therapy research 8
- Cancer Immunotherapy and Biomarkers 4
- HER2/EGFR in Cancer Research 2
- Lung Cancer Research Studies 2
-
- Cancer Research and Treatments 7
- Co-authors
- Jill Buck (8 shared papers)Matthew R. Collinson-Pautz (2 shared papers)Partow Kebriaei (2 shared papers)Rimas V. Lukas (6 shared papers)Marcelo V. Negrão (2 shared papers)Maria Pia Morelli (3 shared papers)Ganesh Rao (3 shared papers)E. Antonio Chiocca (5 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)Neuro-Oncology (2 papers)Annals of Oncology (1 paper)Neuro-Oncology Advances (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Nathan Demars
12 papers receiving 35 citations
Peers
Comparison fields: 5 of 16
- Genetics 14
- Oncology 25
- Immunology 11
- Biotechnology 4
- Genetics 9
Countries citing papers authored by Nathan Demars
This map shows the geographic impact of Nathan Demars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Demars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Demars more than expected).
Fields of papers citing papers by Nathan Demars
This network shows the impact of papers produced by Nathan Demars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Demars. The network helps show where Nathan Demars may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathan Demars, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 6 | |
| 2 | 2021 | 6 | |
| 3 | 2019 | 4 | |
| 4 | 2020 | 3 | |
| 5 | 2024 | 3 | |
| 6 | 2016 | 3 | |
| 7 | 2016 | 3 | |
| 8 | 2018 | 3 | |
| 9 | 2022 | 2 | |
| 10 | 2018 | 2 | |
| 11 | 2020 | 1 | |
| 12 | 2020 | 1 | |
| 13 | 2020 | 1 |
About Nathan Demars
Nathan Demars is a scholar working on Oncology, Biotechnology, Genetics, Genetics and Pulmonary and Respiratory Medicine, having authored 13 papers that have together received 38 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Cancer Research and Treatments (7 papers), Virus-based gene therapy research (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), HER2/EGFR in Cancer Research (2 papers), Lung Cancer Research Studies (2 papers), Cancer Genomics and Diagnostics (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Genetics (14 citations), Oncology (25 citations), Immunology (11 citations), Biotechnology (4 citations) and Genetics (9 citations). Nathan Demars has collaborated with scholars based in United States, Germany and France. Frequent co-authors include Jill Buck, Matthew R. Collinson-Pautz, Partow Kebriaei, Rimas V. Lukas, Marcelo V. Negrão, Maria Pia Morelli, Ganesh Rao, E. Antonio Chiocca, John Barrett and Scott Kopetz. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Annals of Oncology and Neuro-Oncology Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.